Revascularization of diaphyseal bone segments by vascular bundle implantation.
Vascularized bone transfer is an effective, established treatment for avascular necrosis and atrophic or infected nonunions. However, limited donor sites and technical difficulty limit its application. Vascular bundle transplantation may provide an alternative. However, even if vascular ingrowth is presumed to occur in such situations, its extent in aiding revascularization for ultimate graft incorporation is not well understood. A rabbit tibia model was used to study and compare vascularized, segmental, diaphyseal, nonvascularized conventional, and vascular bundle-implanted grafts with a combination of angiographic, radiographic, histopathologic, and bone scanning techniques. Complete graft incorporation in conventional grafts was observed at 6 months, whereas it was 8 to 12 weeks with either of the vascularized grafts. The pattern of radionuclide uptake and the duration of graft incorporation between vascular segmental bone grafts (with intact endosteal blood supply) and vascular bundle-implanted segmental grafts were similar. A vascular bundle implanted in the recipient bone was found to anastomose extensively with the intraosseous circulation at 6 weeks. Effective revascularization of bone could be seen when a simple vascular bundle was introduced into a segment of bone deprived of its normal blood supply. This simple technique offers promise for improvement of bone graft survival in clinical circumstances.
Nagi
O N
ON
Department of Orthopaedics, Postgraduate Institute of Medical Education and Research, Chandigarh, India. profnagi@yahoo.co.in
D000818:Animals; D001861:Bone Regeneration / Q000502:physiology; D016025:Bone Transplantation / Q000502:physiology*; D001842:Bone and Bones / Q000098:blood supply* / Q000000981:diagnostic imaging; D008297:Male; D023421:Models, Animal; D011817:Rabbits; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate; D013977:Tibia / Q000098:blood supply
D019275:Radiopharmaceuticals; D013669:Technetium Tc 99m Medronate